ReviewCell biochemistry and biophysics2026
Phytochemicals Modulating Redox Homeostasis in Head and Neck Cancer.
Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species regulate many biological processes and need constant surveillance and fine-tuning. Oxidative stress can result in the initiation & progression of various cancers including Head and Neck Cancers [HNCs]. The diversity in the structure of the phytochemicals enable them to modulate the redox homeostasis at molecular, biochemical & cellular levels. Understanding the redox regulatory mechanisms induced by phytochemicals is of interest to develop therapeutics against cancers, especially head and neck cancers. Phytochemicals offer multiple benefits compared to synthetic drugs, such as being more affordable, having fewer or no side effects, and being more accessible to the general population. Targeted therapies including immunotherapies, oral microbiome as well as phytochemicals are important factors in the prevention and treatment of HNC. Phytochemicals, besides having chemopreventive & chemotherapeutic role in cancer, can also modulate microbiota indirectly influencing the therapeutic outcome. Despite advancements in therapeutic modalities and emergence of new therapies, management and treatment of HNC is still elusive. Heterogeneity, poor prognosis, invasiveness, and resistance to conventional therapies have been the major road blocks. This review aims to explore and identify new therapeutic approaches for addressing targets linked to redox imbalances. The use of phytochemicals to modulate redox homeostasis at almost all stages of HNC can give a better opportunity for early detection, and prevention leading to improved quality of life for patients. Further development of probes that can detect ROS, for precise therapeutic outcome of phytochemical treatments can also be an important strategy.
Indexed as
Identifiers
41004017What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.